Final time plan for the Rights Issue, QuickCool AB (publ)

Report this content

On Monday 19 November, 2018, at 17.00, an extraordinary general meeting was held at QuickCool AB (publ) at the company's premises in Lund. Please note that the time plan differs slightly form the one originally presented in the notice for the EGM.
The final time plan for the rights issue is presented below:

22 November 2018 Last day for trading of QuickCool share, including the preferential right to participate in the Rights Issue
23 November 2018 First day for trading of QuickCool share, excluding the preferential right to participate in the Rights Issue
26 November 2018 Day for recording the ones who are entitled to the preferential right to participate in the Rights Issue
About 27 November 2018 Memorandum is published
28 November – 12 December 2018 Subscription period
28 November – 10 December 2018 Trading period of URs on Spotlight Stock Market
28 November 2018 (onwards) Trading period of BTAs until the rights issue is registered with the Swedish Companies Registration Office
About 14 December 2018 Publication of final outcome in the Rights Issue

For more information, please contact:
Fredrik Radencrantz, VD
Telefon: 046-286 38 40

QuickCool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the QuickCool SYSTEM. QuickCool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. QuickCool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to:


Documents & Links